TCM

Tekla Capital Management Portfolio holdings

AUM $2.56B
1-Year Est. Return 18.15%
This Quarter Est. Return
1 Year Est. Return
+18.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.59B
AUM Growth
-$205M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
169
New
Increased
Reduced
Closed

Top Buys

1
+$42.1M
2
+$23.4M
3
+$21.4M
4
CELG
Celgene Corp
CELG
+$13.2M
5
SAGE
Sage Therapeutics
SAGE
+$11.2M

Top Sells

1
+$25.8M
2
+$23.6M
3
+$21.4M
4
GILD icon
Gilead Sciences
GILD
+$20.1M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$18.4M

Sector Composition

1 Healthcare 92.75%
2 Real Estate 2.87%
3 Financials 0.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$181M 6.96%
2,520,281
-280,850
2
$158M 6.09%
1,513,904
+126,379
3
$150M 5.78%
862,174
+241,900
4
$142M 5.48%
445,607
-43,997
5
$103M 3.97%
736,132
-62,800
6
$96.5M 3.72%
643,762
-87,361
7
$78.9M 3.04%
659,618
-91,287
8
$74.4M 2.87%
1,385,660
-158,353
9
$67.8M 2.62%
1,603,112
10
$67.4M 2.6%
305,886
+30,060
11
$65.7M 2.53%
693,275
12
$64.1M 2.47%
170,516
13
$62.4M 2.41%
293,793
-31,765
14
$45.6M 1.76%
798,619
-452,301
15
$43.7M 1.68%
489,745
-12,000
16
$40.9M 1.58%
506,026
-74,300
17
$35.3M 1.36%
1,027,742
+173,910
18
$34.4M 1.33%
138,556
+13,775
19
$34.1M 1.31%
208,180
-130,799
20
$33.5M 1.29%
346,313
+241,800
21
$32.4M 1.25%
383,099
-5,001
22
$32.1M 1.24%
426,180
-18,727
23
$31.3M 1.21%
201,739
-50,374
24
$30M 1.16%
1,583,108
-173,450
25
$26.6M 1.02%
366,521
-45,370
1
2 3 4 5